Major developments in the Alzheimer’s drug space and investments into healthtech episode artwork

EPISODE · Sep 30, 2021 · 12 MIN

Major developments in the Alzheimer’s drug space and investments into healthtech

from Dealcast: The M&A Podcast

We’ve made it easier to go from selling to sold.Our easy-to-use M&A Checklist drawn from more than 20 years of VDR experience ensures you have everything you need to get the deal done. Never missing a step means deals go full speed ahead.For a limited time, get your M&A Checklist covering key areas, including:FinanceLabor relationsIntellectual propertyRegulatory and legal mattersPlus 8 more critical categoriesVisit: intralinks.com

Episode metadata supplied by the publisher feed · Published Sep 30, 2021

Embed this episode

This week’s episode we’re looking at some of the major developments in the Alzheimer’s drug space and how that’s impacting corporate activity. Joining Julie-Anna Needham is Dane Hamilton, Healthcare Editor for Acuris.

Distinct summary based on available episode metadata or transcript content.

Ready to play

Major developments in the Alzheimer’s drug space and investments into healthtech

0:00 12:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dealcast: The M&A Podcast?

This episode is 12 minutes long.

When was this Dealcast: The M&A Podcast episode published?

This episode was published on September 30, 2021.

Can I download this Dealcast: The M&A Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!